These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21640327)

  • 1. Dabigatran falsely elevates point of care international normalized ratio results.
    DeRemer CE; Gujral JS; Thornton JW; Sorrentino RA
    Am J Med; 2011 Sep; 124(9):e5-6. PubMed ID: 21640327
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential inaccuracy of point-of-care INR in dabigatran-treated patients.
    Baruch L; Sherman O
    Ann Pharmacother; 2011 Jul; 45(7-8):e40. PubMed ID: 21712509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretation of point-of-care INR results in patients treated with dabigatran.
    van Ryn J; Baruch L; Clemens A
    Am J Med; 2012 Apr; 125(4):417-20. PubMed ID: 22306274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating and assessing dabigatran drug interactions.
    Nguyen T; Wong E
    Consult Pharm; 2012 Jul; 27(7):509-12. PubMed ID: 22910132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atrial fibrillation: what the GP needs to know].
    Diener HC; Kaeufer T; Bode C
    MMW Fortschr Med; 2011 Sep; 153(38):44-7; quiz 48. PubMed ID: 21977796
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurosurgical complications of direct thrombin inhibitors--catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran.
    Garber ST; Sivakumar W; Schmidt RH
    J Neurosurg; 2012 May; 116(5):1093-6. PubMed ID: 22394293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct thrombin inhibitors: a case indicating benefit from 'plasmapheresis' in toxicity: a call for establishing "guidelines" in overdose and to find an "antidote"!
    Kamboj J; Kottalgi M; Cirra VR; Shah N; Kamboj R
    Am J Ther; 2012 Nov; 19(6):e182-5. PubMed ID: 23154229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The successful management of dabigatran-associated critical end-organ bleeding with recombinant factor VIIa.
    Htun KT; McFadyen J; Tran HA
    Ann Hematol; 2014 Oct; 93(10):1785-6. PubMed ID: 24584995
    [No Abstract]   [Full Text] [Related]  

  • 9. Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.
    Wychowski MK; Kouides PA
    Ann Pharmacother; 2012 Apr; 46(4):e10. PubMed ID: 22496474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
    Escobar C; Barrios V; Jimenez D
    Cardiovasc Ther; 2010 Oct; 28(5):295-301. PubMed ID: 20718760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dabigatran: uncharted waters and potential harms.
    Radecki RP
    Ann Intern Med; 2012 Jul; 157(1):66-8. PubMed ID: 22751762
    [No Abstract]   [Full Text] [Related]  

  • 12. Place of dabigatran in contemporary pharmacotherapy.
    Gums JG
    Pharmacotherapy; 2011 Apr; 31(4):335-7. PubMed ID: 21449622
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological sheet. Dabigatran, oral administration (Pradaxa)].
    Duh PD; Leuckx PS; Warnez PM
    J Pharm Belg; 2012 Mar; (1):37-8. PubMed ID: 22536682
    [No Abstract]   [Full Text] [Related]  

  • 14. [New anticoagulants: stop or more?].
    Laroche JP
    J Mal Vasc; 2014 Feb; 39(1):1-3. PubMed ID: 24412008
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical challenges in a patient with dabigatran-induced fatal hemorrhage.
    Cano EL; Miyares MA
    Am J Geriatr Pharmacother; 2012 Apr; 10(2):160-3. PubMed ID: 22386824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.
    Bendel SD; Bona R; Baker WL
    Adv Ther; 2011 Jun; 28(6):460-72. PubMed ID: 21533567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
    Shah SV; Gage BF
    Circulation; 2011 Jun; 123(22):2562-70. PubMed ID: 21606397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
    Nagarakanti R; Ezekowitz MD; Oldgren J; Yang S; Chernick M; Aikens TH; Flaker G; Brugada J; Kamensky G; Parekh A; Reilly PA; Yusuf S; Connolly SJ
    Circulation; 2011 Jan; 123(2):131-6. PubMed ID: 21200007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dabigatran induced exanthema].
    Cucurull i Canosa J; Vega-Molpeceres S; Just Sarobe M; Escoda García M
    Rev Clin Esp; 2010 Dec; 210(11):590-1. PubMed ID: 21074757
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation assays.
    Bates SM; Weitz JI
    Circulation; 2005 Jul; 112(4):e53-60. PubMed ID: 16043649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.